statistical analysis software program, version 9.4 or later (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statistical analysis software program, version 9.4 or later
Statistical Analysis Software Program, Version 9.4 Or Later, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+analysis+program+version+9%2E4/software+version+9+4/pmc10481925-67-7-14
Average 90 stars, based on 1 article reviews
Statistical Analysis Software Program, Version 9.4 Or Later, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+analysis+program+version+9%2E4/software+version+9+4/pmc10481925-67-7-14
Average 90 stars, based on 1 article reviews
statistical analysis software program, version 9.4 or later - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Vaccines:Article Title: A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases Article Snippet: All analyses were carried out using the Article Title: Outpatient orthopaedic trauma surgery: is it safe? Article Snippet: Descriptive statistics were used to characterize our patient population regarding demographics, original mechanism of injury, OTA/AO fracture classification, and operative characteristics, using Article Title: U.S. adults with diagnosed diabetes enrolled in Medicare by age and insurance type Article Snippet: Article Title: Evaluating health-related quality of life and health resource utilization among Gabapentinoid users with substance use disorder in the US: Trends, co-prescriptions, and cost analysis Article Snippet: All analyses were performed using Article Title: Effects of Pistachio Consumption on Inflammatory Markers and Lean Body Mass in Recreationally Active Women and Men Article Snippet: Randomization allocation tables will be created by a biostatistician not involved in the clinical trial using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: All analyses were performed via Article Title: Initial surgery versus conservative management of chronic severe aortic regurgitation in mild symptomatic older patients Article Snippet: All statistical analyses were performed using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: Randomization of eligible participants to vaccines was conducted by an independent statistician using Software:Article Title: A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases Article Snippet: All analyses were carried out using the Article Title: Outpatient orthopaedic trauma surgery: is it safe? Article Snippet: Descriptive statistics were used to characterize our patient population regarding demographics, original mechanism of injury, OTA/AO fracture classification, and operative characteristics, using Article Title: U.S. adults with diagnosed diabetes enrolled in Medicare by age and insurance type Article Snippet: Article Title: Evaluating health-related quality of life and health resource utilization among Gabapentinoid users with substance use disorder in the US: Trends, co-prescriptions, and cost analysis Article Snippet: All analyses were performed using Article Title: Effects of Pistachio Consumption on Inflammatory Markers and Lean Body Mass in Recreationally Active Women and Men Article Snippet: Randomization allocation tables will be created by a biostatistician not involved in the clinical trial using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: All analyses were performed via Article Title: Initial surgery versus conservative management of chronic severe aortic regurgitation in mild symptomatic older patients Article Snippet: All statistical analyses were performed using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: Randomization of eligible participants to vaccines was conducted by an independent statistician using Blocking Assay:Article Title: A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases Article Snippet: All analyses were carried out using the Article Title: Outpatient orthopaedic trauma surgery: is it safe? Article Snippet: Descriptive statistics were used to characterize our patient population regarding demographics, original mechanism of injury, OTA/AO fracture classification, and operative characteristics, using Article Title: U.S. adults with diagnosed diabetes enrolled in Medicare by age and insurance type Article Snippet: Article Title: Evaluating health-related quality of life and health resource utilization among Gabapentinoid users with substance use disorder in the US: Trends, co-prescriptions, and cost analysis Article Snippet: All analyses were performed using Article Title: Effects of Pistachio Consumption on Inflammatory Markers and Lean Body Mass in Recreationally Active Women and Men Article Snippet: Randomization allocation tables will be created by a biostatistician not involved in the clinical trial using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: All analyses were performed via Article Title: Initial surgery versus conservative management of chronic severe aortic regurgitation in mild symptomatic older patients Article Snippet: All statistical analyses were performed using Article Title: Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial. Article Snippet: Randomization of eligible participants to vaccines was conducted by an independent statistician using |